Advancing Drug Discovery Through Academic–Industry Collaboration

Genestack recently announced that they were joining the Milner Therapeutics Institute. Genestack, a bioinformatics company, will support the management, aggregation and analysis of data generated by both academic and pharmaceutical partners. The institute’s mission is to convert scientific research into promising therapies, connecting academic and industry sectors, enabling successful collaborative research ventures, and accelerating the creation of new biotech companies with a therapeutic focus.„

“In light of the announcement, I spoke to Prof. Tony Kouzarides, Director of the Milner Therapeutics Institute and Dr. Misha Kapushesky, Founder and CEO of Genestack, to learn more about the institute, the new partnership, its impact on drug development, the importance of collaboration, and challenges within the drug discovery field.„

Read the full article by Technology Networks. 

Latest In the Blog